Seto WK - Search Results

1

Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world study.

Lee CH, Lui DT, Mak LY, Fong CH, Chan KS, Mak JH, Cheung CY, Chow WS, Woo YC, Yuen MF, Seto WK, Lam KS. Lee CH, et al. Among authors: seto wk. Diabetes Obes Metab. 2024 Nov 5. doi: 10.1111/dom.16049. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39497579

2

Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.

Yuen MF, Seto WK, Chow DH, Tsui K, Wong DK, Ngai VW, Wong BC, Fung J, Yuen JC, Lai CL. Yuen MF, et al. Among authors: seto wk. Antivir Ther. 2007;12(8):1295-303. Antivir Ther. 2007. PMID: 18240869 Clinical Trial.

3

Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.

Yuen MF, Fung J, Seto WK, Wong DK, Yuen JC, Lai CL. Yuen MF, et al. Among authors: seto wk. Antivir Ther. 2009;14(5):679-85. Antivir Ther. 2009. PMID: 19704171 Clinical Trial.

4

Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.

Fung J, Lai CL, Chan SC, But D, Seto WK, Cheng C, Wong DK, Lo CM, Fan ST, Yuen MF. Fung J, et al. Among authors: seto wk. Am J Gastroenterol. 2010 May;105(5):1116-22. doi: 10.1038/ajg.2009.665. Epub 2009 Nov 17. Am J Gastroenterol. 2010. PMID: 19920809

5

Natural history of chronic hepatitis C: genotype 1 versus genotype 6.

Seto WK, Lai CL, Fung J, Hung I, Yuen J, Young J, Wong DK, Yuen MF. Seto WK, et al. J Hepatol. 2010 Sep;53(3):444-8. doi: 10.1016/j.jhep.2010.04.009. Epub 2010 May 26. J Hepatol. 2010. PMID: 20554340

6

Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population.

Yuen MF, Lee CK, Wong DK, Fung J, Hung I, Hsu A, But DY, Cheung TK, Chan P, Yuen JC, Fung FK, Seto WK, Lin CK, Lai CL. Yuen MF, et al. Among authors: seto wk. Gut. 2010 Oct;59(10):1389-93. doi: 10.1136/gut.2010.209148. Epub 2010 Jul 30. Gut. 2010. PMID: 20675695 Free article.

7

Profile of pre-S deletions in the natural history of chronic hepatitis B infection.

Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF. Yeung P, et al. Among authors: seto wk. J Med Virol. 2010 Nov;82(11):1843-9. doi: 10.1002/jmv.21901. J Med Virol. 2010. PMID: 20872710

8

Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy.

Fung J, Seto WK, Lai CL, Yuen J, Wong DK, Yuen MF. Fung J, et al. Among authors: seto wk. J Hepatol. 2011 Feb;54(2):195-200. doi: 10.1016/j.jhep.2010.06.031. Epub 2010 Oct 19. J Hepatol. 2011. PMID: 21056499

9

Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome.

Seto WK, Lai CL, Fung J, Wong DK, Yuen JC, Hung IF, Yuen MF. Seto WK, et al. J Hepatol. 2011 Sep;55(3):522-528. doi: 10.1016/j.jhep.2010.11.018. Epub 2010 Dec 13. J Hepatol. 2011. PMID: 21147187

10

Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.

Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF. Yeung P, et al. Among authors: seto wk. J Infect Dis. 2011 Mar 1;203(5):646-54. doi: 10.1093/infdis/jiq096. Epub 2011 Jan 12. J Infect Dis. 2011. PMID: 21227916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters